RG 108, non-nucleoside DNA methyltransferase inhibitor (DNMT)
Be the first to review this product! Submit a review
|
(4 Publications)
MW 334.3 Da, Purity >99%. Novel, non-nucleoside DNA methyltransferase (DNMT) inhibitor, capable of interacting with the DNMT1 active site (IC50 = 115 nM). Inhibits DNA methylation in human cancer cell lines. Reactivates several epigenetically silenced tumour suppressor genes in vitro. Capable of enhancing the efficiency of induced pluripotent stem cell (iPS) generation.
View Alternative Names
ADCADN, AIM, CXXC finger protein 9, CXXC-type zinc finger protein 9, CXXC9, DNA (cytosine-5)-methyltransferase 1, DNA MTase, DNA MTase HsaI, DNA methyltransferase 1, DNA methyltransferase HsaI, DNA methyltransferase M.HsaI., DNMT, DNMT1_HUMAN, Dnmt1o, FLJ16293, HSN1E, M.HsaI, MCMT, MGC104992, Met1, MommeD2, mMmul
- Chemical Structure
Lab
Chemical Structure - RG 108, non-nucleoside DNA methyltransferase inhibitor (DNMT) (AB141013)
2D chemical structure image of ab141013, RG 108, non-nucleoside DNA methyltransferase inhibitor (DNMT)
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Pain research & management 2020:1528362 PubMed32148597
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 24:1599-1610 PubMed30224758
2018
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 11:332 PubMed30258352
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:10152 PubMed28860604
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com